Logo image of AOSL

ALPHA & OMEGA SEMICONDUCTOR (AOSL) Stock Fundamental Analysis

USA - NASDAQ:AOSL - BMG6331P1041 - Common Stock

18.93 USD
-0.99 (-4.97%)
Last: 11/11/2025, 8:00:01 PM
18.93 USD
0 (0%)
After Hours: 11/11/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AOSL. AOSL was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. AOSL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, AOSL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AOSL was profitable.
In the past year AOSL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AOSL reported negative net income in multiple years.
In the past 5 years AOSL always reported a positive cash flow from operatings.
AOSL Yearly Net Income VS EBIT VS OCF VS FCFAOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

AOSL has a worse Return On Assets (-9.38%) than 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -11.79%, AOSL is doing worse than 69.64% of the companies in the same industry.
Industry RankSector Rank
ROA -9.38%
ROE -11.79%
ROIC N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
AOSL Yearly ROA, ROE, ROICAOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

AOSL's Gross Margin of 23.13% is on the low side compared to the rest of the industry. AOSL is outperformed by 78.57% of its industry peers.
In the last couple of years the Gross Margin of AOSL has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AOSL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
AOSL Yearly Profit, Operating, Gross MarginsAOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. Health

2.1 Basic Checks

AOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AOSL has more shares outstanding
The number of shares outstanding for AOSL has been increased compared to 5 years ago.
The debt/assets ratio for AOSL has been reduced compared to a year ago.
AOSL Yearly Shares OutstandingAOSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
AOSL Yearly Total Debt VS Total AssetsAOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.28 indicates that AOSL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.28, AOSL is in line with its industry, outperforming 51.79% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that AOSL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, AOSL is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 3.28
ROIC/WACCN/A
WACC10.85%
AOSL Yearly LT Debt VS Equity VS FCFAOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

AOSL has a Current Ratio of 2.56. This indicates that AOSL is financially healthy and has no problem in meeting its short term obligations.
AOSL has a Current ratio (2.56) which is comparable to the rest of the industry.
AOSL has a Quick Ratio of 1.34. This is a normal value and indicates that AOSL is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.34, AOSL is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.34
AOSL Yearly Current Assets VS Current LiabilitesAOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

AOSL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.00%.
The earnings per share for AOSL have been decreasing by -24.39% on average. This is quite bad
Looking at the last year, AOSL shows a small growth in Revenue. The Revenue has grown by 5.92% in the last year.
The Revenue has been growing by 8.41% on average over the past years. This is quite good.
EPS 1Y (TTM)-72%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)5.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%0.34%

3.2 Future

Based on estimates for the next years, AOSL will show a very strong growth in Earnings Per Share. The EPS will grow by 75.81% on average per year.
Based on estimates for the next years, AOSL will show a small growth in Revenue. The Revenue will grow by 5.55% on average per year.
EPS Next Y-32%
EPS Next 2Y75.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.46%
Revenue Next 2Y5.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AOSL Yearly Revenue VS EstimatesAOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
AOSL Yearly EPS VS EstimatesAOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 135.21, AOSL can be considered very expensive at the moment.
AOSL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.35. AOSL is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 27.84, which means the current valuation is very expensive for AOSL.
AOSL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AOSL is cheaper than 61.61% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AOSL to the average of the S&P500 Index (33.72), we can say AOSL is valued inline with the index average.
Industry RankSector Rank
PE 135.21
Fwd PE 27.84
AOSL Price Earnings VS Forward Price EarningsAOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AOSL indicates a rather cheap valuation: AOSL is cheaper than 84.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.57
AOSL Per share dataAOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as AOSL's earnings are expected to grow with 75.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.81%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AOSL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALPHA & OMEGA SEMICONDUCTOR

NASDAQ:AOSL (11/11/2025, 8:00:01 PM)

After market: 18.93 0 (0%)

18.93

-0.99 (-4.97%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-03 2026-02-03
Inst Owners73.2%
Inst Owner Change1.62%
Ins Owners16.54%
Ins Owner Change-0.74%
Market Cap568.66M
Revenue(TTM)696.16M
Net Income(TTM)-96.98M
Analysts80
Price Target34.34 (81.41%)
Short Float %5.33%
Short Ratio5.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)168.63%
Min EPS beat(2)41.18%
Max EPS beat(2)296.08%
EPS beat(4)3
Avg EPS beat(4)85.28%
Min EPS beat(4)-6.42%
Max EPS beat(4)296.08%
EPS beat(8)7
Avg EPS beat(8)71.97%
EPS beat(12)8
Avg EPS beat(12)103.31%
EPS beat(16)12
Avg EPS beat(16)80.12%
Revenue beat(2)2
Avg Revenue beat(2)2.22%
Min Revenue beat(2)1.78%
Max Revenue beat(2)2.65%
Revenue beat(4)2
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-0.97%
Max Revenue beat(4)2.65%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)3
Avg Revenue beat(12)-0.84%
Revenue beat(16)7
Avg Revenue beat(16)-0.29%
PT rev (1m)9.78%
PT rev (3m)9.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)-45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE 135.21
Fwd PE 27.84
P/S 0.82
P/FCF N/A
P/OCF 19.17
P/B 0.69
P/tB 0.69
EV/EBITDA 13.57
EPS(TTM)0.14
EY0.74%
EPS(NY)0.68
Fwd EY3.59%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.99
OCFY5.22%
SpS23.17
BVpS27.37
TBVpS27.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number9.29
Profitability
Industry RankSector Rank
ROA -9.38%
ROE -11.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.13%
FCFM N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
F-Score4
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.46
Cap/Depr 59.59%
Cap/Sales 5.34%
Interest Coverage N/A
Cash Conversion 84.86%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 1.34
Altman-Z 3.28
F-Score4
WACC10.85%
ROIC/WACCN/A
Cap/Depr(3y)128.04%
Cap/Depr(5y)168.75%
Cap/Sales(3y)8.98%
Cap/Sales(5y)11.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-38.1%
EPS Next Y-32%
EPS Next 2Y75.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%0.34%
Revenue Next Year3.46%
Revenue Next 2Y5.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-634.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year582.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.39%
OCF growth 3Y-48.63%
OCF growth 5Y-13.79%

ALPHA & OMEGA SEMICONDUCTOR / AOSL FAQ

Can you provide the ChartMill fundamental rating for ALPHA & OMEGA SEMICONDUCTOR?

ChartMill assigns a fundamental rating of 3 / 10 to AOSL.


What is the valuation status for AOSL stock?

ChartMill assigns a valuation rating of 3 / 10 to ALPHA & OMEGA SEMICONDUCTOR (AOSL). This can be considered as Overvalued.


How profitable is ALPHA & OMEGA SEMICONDUCTOR (AOSL) stock?

ALPHA & OMEGA SEMICONDUCTOR (AOSL) has a profitability rating of 2 / 10.


How financially healthy is ALPHA & OMEGA SEMICONDUCTOR?

The financial health rating of ALPHA & OMEGA SEMICONDUCTOR (AOSL) is 4 / 10.